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Background: The optimal anaesthetic modality for endovascular treatment (EVT) in acute 29 
ischaemic stroke (AIS) is undetermined. Comparisons of general anaesthesia (GA) with 30 
composite non-GA cohorts of conscious sedation (CS) and local anaesthesia (LA) without 31 
sedation have provided conflicting results. There has been emerging interest in assessing 32 
whether LA alone may be associated with improved outcomes. We conducted a systematic-33 
review and meta-analysis to evaluate clinical and procedural outcomes comparing LA to CS 34 
and GA.  35 
 36 
Methods: We reviewed the literature for studies reporting outcome variables in LA versus 37 
CS and LA versus GA comparisons. The primary outcome was 90-day good functional 38 
outcome (modified Rankin Scale (mRS≤2). Secondary outcomes included mortality, 39 
symptomatic intracerebral haemorrhage, excellent functional outcome (mRS≤1), successful 40 
reperfusion (thrombolysis in cerebral infarction (TICI)>2b), procedural time metrics and 41 
procedural complications. Random effects meta-analysis was performed on unadjusted and 42 
adjusted data.  43 
 44 
Results: Eight non-randomised studies of 7797 patients (2797 LA, 2218 CS, 2782 GA) were 45 
identified. In the LA versus GA comparison, no statistical differences were found in 46 
unadjusted analyses for 90-day good functional outcome or mortality (OR=1.22, 95%CI 47 
0.84-1.76, p=0.3 and OR=0.83, 95%CI 0.64-1.07, p=0.15 respectively) or in the LA versus 48 
CS comparison (OR=1.14, 95%CI 0.76-1.71, p=0.53 and OR=0.88, 95%CI 0.62-1.24, p=0.47 49 
respectively). There was a tendency towards achieving excellent functional outcome 50 
(mRS≤1) in the LA group versus GA (OR=1.44, 95%CI 1.00-2.08, p=0.05, I2=70%). 51 
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Analysis of adjusted data demonstrated a tendency towards higher odds of death at 90 days in 52 
GA versus LA (OR=1.24, 95%CI 1.00-1.54, p=0.05 I2=0%). 53 
 54 
Conclusion: LA without sedation was not significantly superior to CS or GA in improving 55 
outcomes when performing EVT for AIS. However, quality of included studies impairs 56 
interpretation and inclusion of a LA arm in future well-designed multi-centre randomised 57 
controlled trials is warranted. 58 
 59 
 60 





Endovascular treatment (EVT) for acute ischaemic stroke (AIS) can be performed on patients 64 
by way of three approaches 1) local anaesthesia (LA) at the arterial access site without 65 
sedation in awake subjects, 2) administering procedural sedation, commonly referred to as 66 
conscious sedation (CS) or 3) general anaesthesia (GA). Observational studies comparing GA 67 
with composite non-GA cohorts of awake (LA) and sedated (CS) patients have reported 68 
poorer outcomes in patients treated under GA1–3.  Pooled analysis of individual patient level 69 
data from the High Effective Reperfusion Using Multiple Endovascular Devices (HERMES) 70 
collaboration similarly supported the avoidance of GA when feasible4. By contrast, single-71 
centre randomized trials comparing protocol based GA with CS yielded either no difference 72 
or more favourable outcomes in the GA group5–9. These opposing results have been 73 
acknowledged by current guidelines and the optimal anaesthetic modality for EVT remains 74 
undetermined10,11. 75 
 76 
Performing EVT under LA without sedation obviates exposure to the sedative 77 
pharmacological agents administered in CS and GA which potentially directly disrupt 78 
cerebral haemodynamics and alter cardiorespiratory variables (such as PaO2 and arterial 79 
blood pressure) to the detriment of cerebral perfusion12. Another important argument to 80 
perform EVT under LA is the potential delay in initiation of the EVT procedure under CS 81 
and GA due to sedation and/or intubation4. These considerations have been recognised by 82 
calls to include LA without sedation as a distinct comparator in prospective studies assessing 83 
the optimal anaesthetic strategy13. To our knowledge, there are no on-going randomised 84 




Retrospective data differentiating subjects receiving LA without sedation from CS and GA 87 
has recently been published but individual studies have reported conflicting results for the 88 
functional outcomes between the LA, CS and GA cohorts14–21.  Hence, the objective of this 89 
systematic and meta-analysis was to assess if LA without sedation resulted in superior 90 
procedural and clinical outcomes, compared to CS and GA, in AIS patients following EVT.   91 
 92 
METHODS 93 
Search Strategy, study selection and eligibility criteria 94 
The study was performed according to the Preferred Reporting Items for Systematic Reviews 95 
and Meta-Analyses (PRISMA) guidelines22. We systematically searched electronic databases 96 
up to January 2021, including PubMed/MEDLINE, EMBASE, and Cochrane. The following 97 
keywords were used in combination or individually by using the Boolean operators "OR" and 98 
"AND": 'thrombectomy', 'endovascular procedures', 'stroke', ‘anaesthesia’, 'local anaesthesia’ 99 
, ‘general anaesthesia’ and ‘conscious sedation’. The articles were selected in 2 stages. 100 
Firstly, the titles and abstracts were screened for relevant studies, and duplicates excluded. 101 
Secondly, the full texts were downloaded and assessed for eligibility. The reference lists of 102 
included publications were then hand-searched for additional relevant studies. This process 103 
was carried out by three assessors independently (WB, PD, AP). Any differences were 104 
resolved by consensus.  105 
Studies evaluating one or more procedural and clinical outcomes of EVT in LA compared to 106 
CS or LA compared to GA were included. LA was defined as the use of subcutaneous 107 
anaesthetic injection only at the site of the arteriotomy, GA required the need for 108 
endotracheal intubation and CS required the need for systemic medication for sedation, 109 
without requiring advanced airway protection. Randomized and non-randomized controlled 110 
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(retrospective and prospective) trials and pre- and post-intervention studies, observational and 111 
cohort studies or post-hoc analyses of observational data in trials were included when a 112 
control group was reported. The exclusion criteria included studies published before 2010 113 
(prior to the use of modern stent retrievers/aspiration), review articles and meta-analyses, 114 
guidelines, technical notes, studies in animals, studies in languages other than English, 115 
studies that did not discriminate between CS and LA in the comparator arm and studies that 116 
did not report our specified outcome measures. In the event of overlapping patient 117 
population, only the series with the largest number of patients or the most detailed data 118 
reported were included.   119 
Data Extraction 120 
Variables recorded, if available, were first line choice of anaesthetic technique (LA, CS, GA), 121 
study type (retrospective, prospective), study recruitment period, sample size, mean age, 122 
number of males, presence of co-morbidities (atrial fibrillation, hypertension, diabetes, 123 
coronary artery disease, heart failure, hyperlipidaemia, smoking) anatomical region 124 
(anterior/posterior circulation), lateralization of hemispheres (left/right), clot location (ICA, 125 
M1, M2, vertebrobasilar, tandem occlusion), baseline National Institutes of Health Stroke 126 
Scale (NIHSS) and modified Rankin scale (mRS), prior intravenous tissue plasminogen 127 
activator (IV-tPA), Alberta stroke program early CT score (ASPECTS), anaesthesia 128 
conversion, the first-line EVT technique used (aspiration, stent-retriever, combined), onset to 129 
groin puncture time, groin puncture to reperfusion time, total procedure time, number of 130 
passes, successful reperfusion rate and first pass effect [defined as extended or modified 131 
thrombolysis in cerebral infarction (TICI) scale of 2b or above], excellent functional outcome 132 
defined as modified Rankin score of 1 or lower (mRS≤1) at 90 days, good functional 133 
outcome defined as functional independence with a mRS≤2 at 90 days, symptomatic 134 
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intracranial haemorrhage (sICH) defined as any ICH with an increase of the NIHSS score of 135 
4 or more within 24 hours or death, mortality at 90 days, and procedure related 136 
complications, including vessel dissection/perforation, intra-procedural haemorrhage and new 137 
or distal emboli.  138 
Outcome measures 139 
The primary outcome was good functional outcome (mRS≤2) at 90 days. The secondary 140 
clinical outcomes were excellent functional outcome (mRS≤1), mortality and sICH. The 141 
secondary procedural outcomes included successful reperfusion (TICI ³2b), the first pass 142 
effect, procedure related complications, door to groin puncture time, groin puncture to 143 
reperfusion time. 144 
Statistical analysis 145 
Study characteristics and extracted variables were summarized using standard descriptive 146 
statistics. Continuous variables were expressed as means and SD, and categorical variables 147 
were expressed as frequencies or percentages. Meta analyses of binary outcomes were 148 
expressed as odds ratio (OR) with a 95% confidence interval (CI), and continuous variables 149 
as weighted mean difference (MD) with a 95%CI. A random effects model was used. Tests of 150 
heterogeneity were conducted with the Q statistic distributed as a chi-square variate 151 
(assumption of homogeneity of effect sizes). The extent of between-study heterogeneity was 152 
assessed with the I2 statistic. Study heterogeneity I2 values >50% were considered substantial 153 
and >75% deemed considerable heterogeneity.  Funnel plots and Egger’s test were used to 154 
assess publication bias for the primary outcome. ROBINS-I23  tool was used to evaluate the 155 
risk of bias of each study. P-values were two-tailed with values <0.05 considered statistically 156 
significant.  157 
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To account for the between-group heterogeneity in variables due to the inclusion of non-158 
randomized studies, we also performed analyses based on adjusted data for potential 159 
confounders (adjusted OR from regression analyses or propensity matching) using the 160 
generic inverse variance method. Additionally we conducted sub-group analysis for GA vs 161 
non-GA and sub-group analysis for anterior circulation only. Meta-regression was not 162 
specifically performed as there were fewer than ten studies included in our meta-analysis24. 163 
All analyses were implemented using JASP 0.14.1.0 and Review Manager 5.4.1 software.  164 
Ethics 165 
This study is a systematic review and meta-analysis, and no human participant procedure was 166 
involved. Informed consent and ethical approval were not essential for this study.  167 
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RESULTS  168 
Literature search results 169 
We screened 921 titles and abstracts, from which 20 full-text articles were evaluated 170 
(Supplementary Figure 1). Out of those, data was extracted from 8 studies14–21 that met the 171 
inclusion criteria. 913 studies were excluded for not reporting on LA vs GA and/or CS, not 172 
reporting the specified outcome measures, lack of full-text or duplicates.  173 
Characteristics of Included Studies 174 
We included 8 studies published between 2010-2020 describing 7797 patients (2797 LA, 175 
2218 CS and 2782 GA) that underwent EVT due to occlusion in the anterior circulation 176 
(7004 patients) or posterior circulation (793 patients). Six studies were prospective and 2 177 
were retrospective cohort studies. The largest study cohort had 4429 patients (1131 LA, 1285 178 
CA and 2013 GA), whilst the smallest study had 158 patients (111 LA and 47 CS). The 179 
studies are summarised in Table 1. The detailed baseline characteristics are presented in 180 
Supplementary Figure 2. 181 
Clinical outcomes 182 
The type of anaesthesia (LA vs GA) was not associated with the odds of achieving good 183 
functional outcome (mRS≤2) at 90 days (Figure 1; 6 studies; OR=1.22, 95%CI 0.84-1.76, 184 
p=0.3, I2=82%), mortality at 90 days (5 studies; OR=0.83, 95%CI 0.64-1.07, p=0.15, I2=82%, 185 
Table 2) and sICH (6 studies; OR=1.16, 95%CI 0.88-1.58, p=0.26, I2=0%, Table 2).  186 
 187 
Similarly, there was no statistical difference between LA vs CS with respect to good 188 
functional outcome (mRS≤2) at 90 days (Figure 2; 5 studies; OR=1.14, 95%CI 0.76-1.71, 189 
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p=0.53, I2=83%), sICH (5 studies; OR=1.18, 95%CI 0.85-1.64, p=0.33, I2=5%, Table 2) or 190 
mortality at 90 days (4 studies; OR=0.88, 95%CI 0.62-1.24, p=0.47, I2=70%, Table 2).  191 
However, there was a tendency towards achieving excellent functional outcome (mRS≤1) in 192 
the LA group (compared to GA) (3 studies; OR=1.44, 95%CI 1.00-2.08, p=0.05, I2=70%, 193 
Table 2) but not when LA was compared to CS (3 studies; OR=1.40, 95%CI 0.87-2.25, 194 
p=0.16, I2=84%, Table 2).  195 
Procedural Outcomes  196 
The door to groin puncture time was statistically significantly shorter in the LA group 197 
(compared to GA) (3 studies; MD = -14.36 mins, 95%CI -20.91 to -7.81, p<0.0001, I2=64%, 198 
Table 2). However, there was no statistical difference in the groin puncture to reperfusion 199 
time (5 studies; MD= -1.66 mins, 95%CI -8.83 to 5.50, p=0.65, I2=83%, Table 2), successful 200 
reperfusion (TICI ³2b) (6 studies; OR=0.90, 95%CI 0.54 to 1.49, p=0.69, I2=88%, Table 2), 201 
first pass effect (2 studies; OR=1.15, 95%CI 0.63 to 2.12, p=0.65, I2=76%, Table 2), or 202 
frequency of procedure-related complications (4 studies; OR=1.20, 95%CI 0.55 to 2.62, 203 
p=0.65, I2=69%, Table 2).  204 
 205 
Similarly, there was no statistical difference between LA and CS in achieving successful 206 
reperfusion (TICI ³2b) (5 studies; OR=0.92, 95%CI 0.56-1.50, p=0.73, I2=86%, Table 2) or 207 
in the frequency of procedure-related complications (3 studies; OR=1.17, 95%CI 0.74-1.83, 208 
p=0.5, I2=0%, Table 2). Only 1 study reported the first pass effect and door to groin puncture 209 
time for LA vs CS which precluded pooled analysis. However, the groin puncture to 210 
reperfusion time was significantly shorter in the LA group compared to CS (3 studies; MD= -211 
7.31 mins, 95%CI –11.44 to -3.19, p=0.0005, I2=0%, Table 2). 212 
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Analyses on adjusted data 213 
Adjustments for unbalanced variables included at least the age, sex, baseline NIHSS score, 214 
and onset to door time, whilst some studies also included the ASPECTS, co-morbidities, 215 
collaterals, IV-tPA, and blood pressure (baseline systolic or mean arterial pressure). After 216 
extracting data adjusted for potential confounders, there remained no statistically significant 217 
difference between the anaesthesia type and good functional outcome (mRS≤2) at 90 days 218 
(GA vs LA; 5 studies; OR=0.98, 95%CI 0.70-1.37, p=0.89, I2=57%) and (CS vs LA; 2 219 
studies; OR=0.76, 95%CI 0.17-3.45, p=0.72, I2=96%) (Supplementary figure 3). There was a 220 
tendency towards increased odds of mortality for GA at 3 months (GA vs LA; 5 studies; 221 
OR=1.24, 95%CI 1.00-1.54, p=0.05, I2=0%) but not for CS (CS vs LA; 2 studies; OR=1.16, 222 
95%CI 0.41-3.27, p=0.78, I2=91%) (Supplementary figure 4). 223 
Sub-group analysis: GA vs non-GA 224 
In a subgroup analysis of GA vs non-GA (composite of CS and LA), GA was associated with 225 
higher odds of mortality (5 studies; OR=1.18, 95%CI 1.02-1.36, p=0.02, I2=8%) but no 226 
statistical difference was demonstrated for good functional outcome (mRS≤2) at 90 days (6 227 
studies; OR=0.87, 95%CI 0.63-1.22, p=0.42, I2=79%) and sICH (6 studies; OR=0.90, 95%CI 228 
0.69-1.18, p=0.45, I2=0%). 229 
Sub-group analysis: anterior circulation  230 
Analysing anterior circulation strokes, we found no statistical difference in the odds of 231 
achieving 90-day good functional outcome (mRS≤2) and mortality respectively between the 232 
LA vs GA groups (4 studies; OR=1.24, 95%CI 0.62-2.47, p=0.54, I2=87%) and (3 studies; 233 
OR = 0.93, 95%CI 0.74-1.17, p=0.55, I2=0%). There were also no differences in the LA vs 234 
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CS comparison (3 studies; OR = 1.20, 95%CI 0.53-2.70, p=0.66, I2=91%) and (2 studies; OR 235 
= 0.98, 95%CI 0.51-1.90, p=0.96, I2=85%). 236 
Risk of bias 237 
All studies had an overall moderate risk of bias (Supplementary Figure 5). Visual inspection 238 
of funnel plots did not reveal asymmetry in studies that reported the primary outcome 239 
(mRs≤2) at 90 days (Supplementary Figure 6) and there was no evidence of publication bias 240 




In this systematic review and meta-analysis the use of LA without sedation for EVT in AIS 243 
was shown to yield similar rates of good functional outcome (mRS≤2 at 90 days) compared 244 
to CS and GA. No statistical differences were found in mortality, successful re-canalisation 245 
(TICI ³2b), sICH, procedural times or complications in the unadjusted analysis. There was a 246 
tendency towards achieving excellent functional outcome (mRS≤1) in the LA group versus 247 
GA comparison. There was also a tendency towards higher odds of 90-day mortality in GA 248 
versus LA using extracted data adjusted for confounders.   249 
 250 
The findings in our study are difficult to directly compare with recent meta-analyses that 251 
assessed GA versus a merged non-GA (LA and CS) group and did not include any of the 252 
studies in the present analysis. Gravel et al2 found non-GA to be associated with better 90-253 
day functional outcomes and mortality in their unadjusted analysis. Interestingly, Goyal et al3 254 
reported no difference between anaesthesia type (GA vs non-GA) for 90-day good functional 255 
outcomes when excluding studies published before the stent-retriever era. Furthermore, the 256 
difference in their unadjusted analysis did not retain significance when imbalances in baseline 257 
NIHSS scores were factored by way of meta-regression. The studies in our analysis also 258 
predominantly included patients who received modern stent retriever/aspiration treatment and 259 
it is plausible that any potential ‘real world’ effect-size of anaesthetic choice has attenuated 260 
with increasing levels of experience of anaesthesiologists in the setting of EVT for AIS.  261 
 262 
One of the rationales for using LA without sedation is to avoid iatrogenic hypotension from 263 
intravenous or inhaled sedative agents. Samuels et al25 recently reported patients treated 264 
under CS had a lower average procedural BP and more BP drops compared to patients treated 265 
under LA. Whilst there is evidence that blood pressure (BP) drops are associated with poor 266 
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functional outcome due to collateral failure26,27; the neurotoxic or neuroprotective effects of 267 
hypnotic agents and optimal intra- and peri-procedural BP targets during the acute ischaemia-268 
reperfusion injury are incompletely understood28.  Of note, in the present analysis, only one 269 
of the included studies reported intra-procedural BP measurements and found no statistical 270 
differences in their selected haemodynamic parameters18.   271 
 272 
The purported disadvantages of using LA alone are lack of airway protection, patient 273 
movement and patient discomfort. These factors may require conversion to either CS or GA 274 
with resultant delays in procedural times and a theoretical detrimental effect on outcomes. 275 
Our analysis showed a conversion rate of LA to GA (17.5%), comparable to those reported 276 
for CS to GA in the previous randomized trials (15.6% in the anesthesia during stroke 277 
(ANSTROKE) trial6 and 14.2% in the sedation versus intubation for endovascular stroke 278 
treatment (SIESTA) trial5. Conversion rates from CS to GA (8.8%) were however lower in 279 
our analysis. Despite this, Flottmann et al19 found similar rates of functional independence 280 
when the 9.8% of patients in their cohort that required emergency conversion were compared 281 
to the primary anaesthesia groups. On the other hand, LA allows for real-time monitoring of 282 
the patient’s neurological status which may guide intra-procedural treatment decisions. Cost 283 
and length of stay in hospital or intensive care were not assessed as outcome variables but 284 
these are also potential resource factors favouring a LA first strategy29. Radiation exposure 285 
was also not assessed however a recent study reported no difference between GA and CS 286 
comparisons30.  287 
 288 
Unsurprisingly, due to the logistics of anaesthetic induction and intubation, we found 289 
significantly shorter door-to-groin puncture times in the LA group compared to the GA 290 
group, which was also shown to favour LA versus CS in the single study reporting on this 291 
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metric18. No statistical difference was identified in groin puncture-to-reperfusion times in the 292 
LA vs GA comparison (±SD, minutes) 52.5±31.8 and 56.0±34.5 respectively. This is in 293 
contrast to the previous meta-analysis by Goyal et al3 that found statistically significant 294 
longer groin puncture to reperfusion times in the non-GA cohort compared to GA (81.3±32.3 295 
and 75.7±25.8 respectively). This may be explained by the overall marked reduction in the 296 
procedural times between the studies which in turn may reflect continued improvement of 297 
modern-day EVT techniques and increasing levels of operator experience.  In addition to 298 
these factors, refinement in selection of patients likely to remain compliant during EVT 299 
performed under LA without sedation may also explain why no differences were revealed in 300 
successful reperfusion (TICI³2b) or procedural complications. 301 
 302 
Our analysis included several limitations. Firstly, due to the observational design of all 303 
included studies, confounding by indication may have influenced the results. Patient related 304 
factors could have influenced the decision whether or not to perform EVT under LA,CS or 305 
GA. Secondly, there were differences in between-group baseline characteristics, including 306 
baseline NIHSS. Whilst these differences were small, we also performed a meta-analysis of 307 
extracted adjusted data which revealed similar outcomes. Thirdly, four of the included 308 
studies14,16,18,19 provided data on a per-protocol analysis basis, whilst the rest provided data on 309 
the basis of an intention-to-treat analysis, which may have confounded the final outcomes. 310 
Fourthly, a disproportionate number of posterior circulation strokes were included in the GA 311 
group which tend to have worse clinical outcomes. However, no statistically significant 312 
difference remained following sub-group analysis for anterior circulation stroke only.    313 
 314 
Conclusion: 315 
To our knowledge, this is the first meta-analysis assessing LA as a distinct comparator versus 316 
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CS and GA for EVT in AIS. LA without sedation was not significantly superior to CS or GA 317 
in improving functional outcome or mortality. However, as the majority of the data is drawn 318 
from registries, the quality of included studies impairs interpretation; the inclusion of a LA 319 
only arm in future multi-centre randomised trials remains a gold-standard for assessing an 320 
effect size between anaesthetic modalities. Nonetheless, these findings reflect ‘real world’ 321 
practice and conducting a well-designed sufficiently powered trial with generalisability may 322 
prove challenging. In the interim, we advise a patient-tailored and expertise-dependent 323 
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Author, Year of 
Study 
Country  Study 
recruitment 
period  
Study Design  Comparator Sample size, n  Risk of bias  
Benvegnu, 202015  France 2018 Prospective multi centre 
ETIS registry  
LA vs CS LA = 272 
CS = 636 
M 
 
Cappellari, 202014 Italy 2011 to 2017 Prospective multi centre 
IRETAS registry  
LA vs CS vs GA LA = 1131 
CS = 1285 
GA = 2013 
M 
Flottmann, 202019 Germany 2015 to 2018 Retrospective single centre LA vs CS vs GA LA = 794 
CS = 76 
GA = 59 
M 
Goldhoorn, 202016 Netherlands 2014 to 2016 Prospective multi centre 
MR CLEAN registry 
LA vs CS vs GA  LA = 821 
CS = 174 
GA = 381 
 
M 
Marion, 202018 USA 2014 to 2018 Single centre retrospective  LA vs CS LA = 111 
CS = 47 
M 
Pop, 202017 France 2018 to 2018 Prospective multi centre 
observational registry 
LA vs GA  LA = 219 
GA = 142 
M 
Wu, 201920  China 2013 to 2017 Prospective single centre 
observational registry 
LA vs GA LA = 112 
GA = 75 
M 
Wu, 202021 China 2012 to 2018 Prospective single centre 
observational registry 
LA vs GA LA = 71 
GA = 112 
M 
LA = local anaesthesia, CS = conscious sedation, GA = general anaesthesia, ETIS = endovascular treatment in ischaemic stroke, IRETAS = Italian registry of endovascular 433 
treatment in acute stroke, MR CLEAN = multicentre randomized clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands, M = moderate  434 
 435 




LA = local anaesthesia, CS = conscious sedation, GA = general anaesthesia, n = number of events, N = number of patients, SD = standard deviation, OR = odds ratio, 438 
CI = confidence interval, MD = mean difference, mRS = modified Rankin scale, sICH = symptomatic intracranial haemorrhage, TICI = thrombolysis in cerebral 439 
infarction, NA= not available. * = statistically significant 440 
 441 
Table 2: Meta-analysis of outcomes according to anaesthesia types.442 
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Figure 1: Forest plot demonstrating the odds of a good functional outcome (mRS≤2) at 90 449 







Figure 2: Forest plot demonstrating the odds of a good functional outcome (mRS≤2) at 90 457 











LA = local anaesthesia, CS = conscious sedation 467 











LA = local anaesthesia, CS = conscious sedation, GA = general anaesthesia, EVT = endovascular technique, NIHSS = 477 
National Institutes of Health Stroke Scale, mRS = modified Rankin Scale, IV-tPA = intravenous tissue plasminogen activator, 478 
ASPECTS = Alberta stroke program early CT score, HTN = hypertension, DM = diabetes mellitus, AF = atrial fibrillation, 479 
SR = stentretriever, CA = contact aspiration, 480 
 481 





GA, n/N (%) or 
mean±SD/N 
CS, n/N (%) or 
mean±SD/N 
GA+CS, n/N (%) or 
mean±SD/N 
LA, n/N (%) or 
mean±SD/N 
Socio-demographics 
Sample size 2782 2218 5000 2797 
Gender (Male) 1549/2782 (55.7) 1063/2217 (47.9) 2611/4999 (52.2) 1420/2796 (50.8) 
Age (years) 69.2±15.1/2782 71.7±14.2/2218 70.3±14.8/5000 70.9±14.0/2797 
Baseline characteristics 
Baseline NIHSS 18.0±6.6/2601 16.6±6.1/2186 17.4±6.4/4787 15.9±6.7/2792 
Baseline mRS (≤1) 1710/2157 (79.3) 1168/1360 (85.9) 2878/3517 (81.8) 1668/2134 (78.2) 
ASPECTS 9.0±1.8/1757 8.7±1.8/1855 8.8±1.8/3612 8.8±1.6/1827 
Good collaterals 623/1259 (49.5) 366/694 (52.7) 989/1953 (50.6) 496/1255 (39.5) 
IV-thrombolysis 1380/2778 (49.7) 1203/2212 (54.4) 2583/4990 (51.8) 1680/2795 (60.1) 
Anaesthesia conversion N/A 58/661 (8.8) N/A 97/553 (17.5) 
Co-morbidities 
HTN 1526/2420 (63.1) 1265/198 (63.6) 2791/4409 (63.3) 1642/2707 (60.7) 
DM 451/2420 (18.6) 363/1986 (18.3) 814/4406 (18.5) 485/2707 (17.9) 
Hyperlipidaemia 693/2420 (28.6) 552/1983 (27.8) 1245/4403 (28.3) 776/2707 (28.7) 
AF 581/2278 (25.5) 443/1366 (32.4) 1023/3644 (28.1) 690/2251 (30.7) 
Prior Stroke 175/2107 (8.3) 85/1290 (6.6) 260/3397 (7.7) 223/2086 (10.7) 
Smoking 563/2420 (23.3) 410/1959 (20.9) 973/4379 (22.2) 632/2707 (23.3) 
Coronary artery disease 144/1651 (8.7) 243/1735 (14.0) 387/3386 (11.4) 190/1390 (13.7) 
Heart failure 125/1651 (7.6) 82/1069 (7.7) 207/2720 (7.6) 60/1042 (5.8) 
Medications 
Antiplatelet 531/2013 (26.4) 644/1901 (33.9) 1175/3914 (30.0) 487/1367 (35.6) 
Anticoagulation 179/2013 (8.9) 134/1285 (10.4) 313/3298 (9.5) 125/1131 (11.1) 
Statin 296/2013 (14.7) 174/1285 (13.5) 470/3298 (14.3) 188/1131 (16.6) 
Clot Localisation 
Left-hemispheric stroke 343/598 (57.4) 109/221 (49.3) 452/819 (55.2) 641/1257 (51.0) 
ICA 587/2645 (22.2) 472/2216 (21.3) 1059/4861 (21.8) 543/3121 (17.4) 
M1 1055/2645 (39.9) 1069/2216 (48.2) 2124/4861 (43.7) 1439/3121 (46.1) 
M2 239/2570 (9.3) 294/2216 (13.3) 533/4786 (11.1) 343/3009 (11.4) 
Tandem occlusion 290/2189 (13.2) 253/1995 (12.7) 543/4184 (13.0) 229/1679 (13.6) 
Vertebrobasilar 553/2100 (26.3) 98/1330 (7.4) 651/3430 (19.0) 142/1310 (10.8) 
First-line EVT technique 
SR 969/1951 (49.7) 690/1781 (38.7) 1659/3732 (44.5) 1131/2324 (48.7) 
CA 553/1599 (34.6) 504/1625 (31.0) 1057/3224 (32.8) 693/1618 (42.8) 





Supplementary Figure 3: Forest plot demonstrating the odds of a good functional outcome 488 
(mRs≤2) at 90 days between local anaesthesia (LA) and general anaesthesia (GA) or 489 











Supplementary Figure 4: Forest plot demonstrating the odds of death at 90 days between 499 
local anaesthesia (LA) and general anaesthesia (GA) or conscious sedation (CS) using data 500 






Supplementary Figure 5: Risk of bias assessment based on the ROBINS-I tool for non-505 







Supplementary Figure 6: Funnel plot for publication bias for good functional outcome 511 
(mRs≤2) at 90 days between local anaesthesia (LA) and general anaesthesia (GA) or 512 
conscious sedation (CS). 513 
 514 
